NasdaqGS:TLRYPharmaceuticals
Tilray Brands (TLRY) Is Up 5.7% After Narrower Loss, ESOP Shelf Filing and M&A Signal
Tilray Brands, Inc. recently reported its fourth-quarter and full-year results to May 31, 2026, showing sales of US$281.71 million for the quarter and US$915.45 million for the year, alongside a substantially lower net loss than the prior year, and also filed a US$47.69 million shelf registration for 11,355,231 common shares related to its ESOP.
The company’s reduced net loss, combined with management’s plan to use at-the-market equity proceeds for acquisitions similar to its BrewDog...